US Urges States and Businesses to Strengthen Taiwan Ties Amid China Pressure 
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert 
Trump Threatens ABC News Lawsuit Over Lincoln Memorial Reflecting Pool Coverage 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
Rubio Faces Gulf Skepticism Over U.S.-Iran Peace Deal 
US Senate Approves War Powers Resolution Urging Trump to End Iran Military Action 
Russia-Ukraine War: Fresh Strikes Injure Civilians as Fuel Crisis Worsens in Russia 
NATO Chief Tries to Ease Trump Alliance Dispute 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles 
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak 
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy 
Andy Burnham Emerges as Favorite After Keir Starmer Resigns 
President Donald Trump had previously touted a two-drug combination as a potential treatment for the COVID-19. However, the US National Institutes of Health (NIH) warned that using the combination might expose coronavirus patients to some serious side effects.
President Donald Trump previously touted a drug combination as a possible treatment for the coronavirus in press briefings and social media posts. “Hydroxychloroquine and azithromycin, taken together, have a real chance to be one of the biggest game-changers in the history of medicine,” Trump tweeted in March, according to Financial Times. “The FDA has moved mountains - Thank You! Hopefully, they will BOTH (H works better with A, International Journal of Antimicrobial Agents)”
“What do you have to lose?” Trump said a couple of weeks ago. However, the President has been criticized by scientists “for promoting the drugs without conclusive scientific evidence that they work,” Forbes reported. After his comments, there were reported shortages of hydroxychloroquine for patients using the drug as a treatment for rheumatoid arthritis or lupus.
However, a panel from the NIH recommended against the use of hydroxychloroquine and azithromycin because they are “associated with QTc prolongation in patients with COVID-19.” According to Forbes, “QTc prolongation is associated with abnormalities in heart rhythm or sudden cardiac death.”
The experts also warned that the drug combination might result in possible toxicities, according to FT, The toxicities could result in further serious side effects, which include poisoning.
The NIH report was done by a panel of health experts that included members of the team led by Anthony Fauci. The report was published on NIH’s website on Tuesday.
The study involved 368 COVID-19 patients at hospitals run by the Veterans Health Administration. Researchers found out that there were more deaths among patients taking a combination of hydroxychloroquine and azithromycin compared to patients who were not taking the drug combo.
At a recent news conference, Trump promised to look into the NIH report but he also clarified that he is not aware of the study. “There have been some very good reports and perhaps this one’s not a good report, but we’ll be looking at it,” the President said.
